This information is disclosed in accordance with the Securities Markets Act, the
Financial Instruments Trading Act or demands made in the exchange rules.
Per Frankling, Investment Director at Ratos, is leaving in order to become CEO
of the investment company Creades in February 2015 at the latest.
"Per Frankling has worked at Ratos since 2000 and has made a substantial
contribution to many successful deals for the company. I regret that we are
losing an appreciated colleague but understand that this is an exciting
challenge for Per. We wish Per the best of luck in his new role", says Ratos's
CEO Susanna Campbell.
For further information, please contact :
Susanna Campbell, CEO Ratos, +46 8 700 17 00
Emma Rheborg, Head of Corporate Communications Ratos, 08-700 17 20
Financial calendar from Ratos:
Interim report January-September 2014 7 November 2014
Year-end report 2014 19 February 2015
Interim report January-March 2105 7 May 2015
Interim report January-June 2015 14 August 2015
Interim report January-September 2015 6 November 2015
Ratos is a private equity conglomerate. The company's mission is to maximise
shareholder value over time through the professional, active and responsible
exercise of its ownership role in primarily medium to large unlisted Nordic
companies. Ratos's holdings include AH Industries, Aibel, Arcus-Gruppen, Biolin
Scientific, Bisnode, DIAB, Euromaint, GS-Hydro, Hafa Bathroom Group, HENT, HL
Display, Inwido, Jøtul, KVD, Mobile Climate Control, Nebula, Nordic Cinema Group
and SB Seating. Ratos is listed on Nasdaq OMX Stockholm and market
capitalisation amounts to approximately SEK 20 billion.
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
2321 Rosecrans Avenue.
El Segundo, CA 90245 Phone: (800) 307-6627 Fax: (800) 307-3567
25 Basinghall Street,
London EC2V 5HA
UK Phone: +1 866-465-8454